BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37272284)

  • 21. Boron Neutron Capture Therapy in the Treatment of Recurrent Laryngeal Cancer.
    Haapaniemi A; Kankaanranta L; Saat R; Koivunoro H; Saarilahti K; Mäkitie A; Atula T; Joensuu H
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):404-410. PubMed ID: 26797537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The New Generation of Particle Therapy Focused on Boron Element (Boron Neutron Capture Therapy; BNCT) -The World's First Approved BNCT Drug].
    Nakashima H
    Yakugaku Zasshi; 2022; 142(2):155-164. PubMed ID: 35110452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of Neutron Sources and 10B Concentration on Boron Neutron Capture Therapy for Shallow and Deeper Non-small Cell Lung Cancer.
    Yu H; Tang X; Shu D; Liu Y; Geng C; Gong C; Hang S; Chen D
    Health Phys; 2017 Mar; 112(3):258-265. PubMed ID: 28121726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The therapeutic effects on U87 and SAS cells using Proton Linac based Boron Neutron Capture Therapy in Korea.
    Seo IH; Seo HJ; Na D; Yoo M; Schwint A; Kim SH; Lee J; Jeon SJ; Choi JW; Kim WH; Park K; Yee GT; Kim WK
    Appl Radiat Isot; 2023 Jul; 197():110794. PubMed ID: 37054663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of a neural network-based prediction method to calculate the therapeutic dose in boron neutron capture therapy of patients with glioblastoma.
    Tian F; Zhao S; Geng C; Guo C; Wu R; Tang X
    Med Phys; 2023 May; 50(5):3008-3018. PubMed ID: 36647729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PEGylated liposome encapsulating nido-carborane showed significant tumor suppression in boron neutron capture therapy (BNCT).
    Lee W; Sarkar S; Ahn H; Kim JY; Lee YJ; Chang Y; Yoo J
    Biochem Biophys Res Commun; 2020 Feb; 522(3):669-675. PubMed ID: 31787237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Boron neutron capture therapy induces apoptosis of glioma cells through Bcl-2/Bax.
    Wang P; Zhen H; Jiang X; Zhang W; Cheng X; Guo G; Mao X; Zhang X
    BMC Cancer; 2010 Dec; 10():661. PubMed ID: 21122152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Boron neutron capture therapy of brain tumors: an emerging therapeutic modality.
    Barth RF; Soloway AH; Goodman JH; Gahbauer RA; Gupta N; Blue TE; Yang W; Tjarks W
    Neurosurgery; 1999 Mar; 44(3):433-50; discussion 450-1. PubMed ID: 10069580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor Cell-Specific 2'-Fluoro RNA Aptamer Conjugated with
    Vorobyeva MA; Dymova MA; Novopashina DS; Kuligina EV; Timoshenko VV; Kolesnikov IA; Taskaev SY; Richter VA; Venyaminova AG
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic success of boron neutron capture therapy (BNCT) mediated by a chemically non-selective boron agent in an experimental model of oral cancer: a new paradigm in BNCT radiobiology.
    Trivillin VA; Heber EM; Nigg DW; Itoiz ME; Calzetta O; Blaumann H; Longhino J; Schwint AE
    Radiat Res; 2006 Aug; 166(2):387-96. PubMed ID: 16881740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor blood vessel "normalization" improves the therapeutic efficacy of boron neutron capture therapy (BNCT) in experimental oral cancer.
    Molinari AJ; Pozzi EC; Monti Hughes A; Heber EM; Garabalino MA; Thorp SI; Miller M; Itoiz ME; Aromando RF; Nigg DW; Trivillin VA; Schwint AE
    Radiat Res; 2012 Jan; 177(1):59-68. PubMed ID: 21980958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insight into the mechanisms underlying tumor response to boron neutron capture therapy in the hamster cheek pouch oral cancer model.
    Aromando RF; Heber EM; Trivillin VA; Nigg DW; Schwint AE; Itoiz ME
    J Oral Pathol Med; 2009 May; 38(5):448-54. PubMed ID: 19141057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Boronated compounds for imaging guided BNCT applications.
    Geninatti-Crich S; Deagostino A; Toppino A; Alberti D; Venturello P; Aime S
    Anticancer Agents Med Chem; 2012 Jun; 12(5):543-53. PubMed ID: 22263798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phospholipid-Coated Boronic Oxide Nanoparticles as Boron Agents for Boron Neutron Capture Therapy.
    Kawasaki R; Hirano H; Yamana K; Oshige A; Nishimura K; Kono N; Sanada Y; Bando K; Tabata A; Yasukawa N; Azuma H; Takata T; Sakurai Y; Tanaka H; Suzuki M; Tarutani N; Katagiri K; Nagasaki T; Ikeda A
    Chembiochem; 2023 Aug; 24(15):e202300186. PubMed ID: 37069129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Boron containing macromolecules and nanovehicles as delivery agents for neutron capture therapy.
    Wu G; Barth RF; Yang W; Lee RJ; Tjarks W; Backer MV; Backer JM
    Anticancer Agents Med Chem; 2006 Mar; 6(2):167-84. PubMed ID: 16529539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electroporation optimizes the uptake of boron-10 by tumor for boron neutron capture therapy (BNCT) mediated by GB-10: a boron biodistribution study in the hamster cheek pouch oral cancer model.
    Garabalino MA; Olaiz N; Portu A; Saint Martin G; Thorp SI; Pozzi ECC; Curotto P; Itoiz ME; Monti Hughes A; Colombo LL; Nigg DW; Trivillin VA; Marshall G; Schwint AE
    Radiat Environ Biophys; 2019 Aug; 58(3):455-467. PubMed ID: 31123853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Boron neutron capture therapy (BNCT) for the treatment of liver metastases: biodistribution studies of boron compounds in an experimental model.
    Garabalino MA; Monti Hughes A; Molinari AJ; Heber EM; Pozzi EC; Cardoso JE; Colombo LL; Nievas S; Nigg DW; Aromando RF; Itoiz ME; Trivillin VA; Schwint AE
    Radiat Environ Biophys; 2011 Mar; 50(1):199-207. PubMed ID: 21132507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Boron neutron capture therapy for malignant brain tumors.
    Miyatake SI; Wanibuchi M; Hu N; Ono K
    J Neurooncol; 2020 Aug; 149(1):1-11. PubMed ID: 32676954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Possibilities of boron neutron capture therapy in the treatment of malignant brain tumors].
    Kanygin VV; Kichigin AI; Gubanova NV; Taskaev SY
    Vestn Rentgenol Radiol; 2015; (6):36-42. PubMed ID: 26999933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Boronated Derivative of Temozolomide Showing Enhanced Efficacy in Boron Neutron Capture Therapy of Glioblastoma.
    Xiang J; Ma L; Gu Z; Jin H; Zhai H; Tong J; Liang T; Li J; Ren Q; Liu Q
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.